4528 — Ono Pharmaceutical Co Balance Sheet
0.000.00%
- ¥851bn
- ¥855bn
- ¥487bn
- 87
- 57
- 47
- 74
Annual balance sheet for Ono Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | IFRS | — | — | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 104,975 | 116,969 | 164,289 | 204,595 | 210,380 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 84,269 | 99,788 | 114,396 | 136,066 | 139,007 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 247,642 | 281,266 | 345,101 | 413,596 | 455,104 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 113,866 | 112,131 | 108,420 | 104,752 | 105,721 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 745,428 | 739,203 | 882,437 | 913,668 | 1,064,046 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 93,733 | 65,926 | 122,929 | 103,624 | 148,296 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 111,295 | 83,297 | 140,569 | 120,708 | 281,594 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 634,133 | 655,906 | 741,868 | 792,960 | 782,452 |
| Total Liabilities & Shareholders' Equity | 745,428 | 739,203 | 882,437 | 913,668 | 1,064,046 |
| Total Common Shares Outstanding |